10,75 €
3,30 % gestern
L&S, 30. Oktober, 22:54 Uhr
ISIN
US88025U1097
Symbol
TXG
Berichte

10x Genomics Inc - Ordinary Shares - Class A Aktie News

Neutral
PRNewsWire
ein Tag alt
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies PLEASANTON, Calif. , Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of the next generation of its high-performance Flex assay, featuring automation-compatible plate-based multi...
Positiv
The Motley Fool
6 Tage alt
Lancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million. 10x Genomics, a new holding for the investment manager, now accounts for 3.1% of its AUM.
Neutral
PRNewsWire
10 Tage alt
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader researcher community PLEASANTON, Calif. , Oct. 20, 2025 /PRNewswire/ --  10x Genomics, Inc.
Neutral
PRNewsWire
21 Tage alt
PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025.
Neutral
Business Wire
21 Tage alt
SEATTLE--(BUSINESS WIRE)--Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent.
Neutral
Seeking Alpha
etwa 2 Monate alt
10x Genomics, Inc. (NASDAQ:TXG ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Serge Saxonov - Co-Founder, CEO & Director Conference Call Participants Yih-Ming Tu - Morgan Stanley, Research Division Presentation Yih-Ming Tu Research Associate Good morning, everyone. Welcome to day 3 of the Morgan Stanley Global Healthcare Conference.
Neutral
PRNewsWire
etwa 2 Monate alt
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedures PLEASANTON, Calif. and REHOVOT, Israel , Sept.
Neutral
PRNewsWire
2 Monate alt
PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, at 11:30 a.m.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen